25 September 2015
The Garvan Institute in Australia and Genomics England in the UK are to work together to make genomic information more accessible, meaningful and usable.
The two bodies have signed a memorandum of understanding in which they agree to pool their collective expertise on genomics related activitie s to advance genomics medicine in both Australia and the UK. Specifically they will be working to improve the capture of clinical information and integrate it with genomic data.
Professor John Mattick, Executive Director of Garvan, said “This agreement is an important step for both nations. It enables us to use our complementary expertise to advance our shared vision of the global transformation of medicine through the use of genomic information.”
Professor Mark Caulfield, Chief Scientist at Genomics England states “I am delighted we are collaborating with the Garvan Institute of Medical Research in Australia. This Partnership will allow us to share tools and approaches to harmonise datasets in Australia and the UK. Our aim is to support other countries in establishing similar programmes to the 100,000 Genomes Project around the world.”
Garvan’s aim is to contribute to genomics research so as to enable people to lead healthy lifestyles. In the past 50 years, Garvan has played a key role in improving understanding of major diseases such as cancer and diabetes. For example, the institute’s Shane Gray (Associate Professor) is part of a collaboration that has been awarded a further $3.3 million to continue their innovative research to make Islet transplantation therapy a practical option for curing diabetes Type 1.
Genomics England was established by the British Department of health in 2013 to implement the 100,000 Genomes project. The aim of this project is to sequence 100,000 genomes from approximately 70,000 people. The majority of these people have rare diseases or a form of cancer.